IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
10 Juni 2024 - 7:00AM
IMCD Italy expands its Pharmaceuticals presence with the
acquisition of Selechimica
ROTTERDAM, The Netherlands (10 June
2024) – IMCD N.V. (“IMCD” or “Company”), a leading
distributor of speciality chemicals and ingredients, today
announces that IMCD Italy has signed an agreement to acquire 100%
of the shares in Selechimica S.R.L. (“Selechimica”), an Italian
distributor in the pharmaceutical industry.
Headquartered in Milan, Italy, Selechimica
distributes an extensive portfolio of Active Pharmaceutical
Ingredients (APIs). With 3 employees, Selechimica represents
leading suppliers and generated a revenue of approximately
EUR 5 million in the financial year that ended December 31,
2023.
“Selechimica is a valued distributor in the
Italian API market. By acquiring Selechimica, IMCD will further
strengthen its position in the Italian API market. We are eager to
unlock the potential of this acquisition”, comments Marco Madeddu,
Managing Director IMCD Italy.
“This transaction provides exciting
opportunities for Selechimica. IMCD's expertise, knowledge of the
industry and resources will enable further expansion of the product
portfolio and customer base”, says Luca Pesce, Owner of
Selechimica.
The closing of the transaction is subject to
customary closing conditions and is expected to take place end of
June 2024.
Attached, the press release in PDF format and
the main visual.
- PR_IMCD Italy expands its Pharmaceuticals presence with the
acquisition of Selechimica
- IMCD_logo
IMCD NV (TG:INX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
IMCD NV (TG:INX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
